For most of the drugs advantages of taking medications overweighs the potential risks however some drugs could be really dangerous for breastfed baby hence every medication shall be considered separately. In this page we will discuss about purpose of Docetaxel | Sandoz Inc. and its risk associated with lactation. We will also discuss the usage of Docetaxel | Sandoz Inc. and some common side effects associated with Docetaxel | Sandoz Inc..
What is Docetaxel | Sandoz Inc. used for?
1. INDICATIONS AND USAGE Docetaxel Injection is a microtubule inhibitor indicated for: • Breast Cancer (BC): single agent for locally advanced or metastatic BC after chemotherapy failure; and with doxorubicin and cyclophosphamide as adjuvant treatment of operable node-positive BC (1.1) • Non-Small Cell Lung Cancer (NSCLC): single agent for locally advanced or metastatic NSCLC after platinum therapy failure; and with cisplatin for unresectable, locally advanced or metastatic untreated NSCLC (1.2) • Hormone Refractory Prostate Cancer (HRPC): with prednisone in androgen independent (hormone refractory) metastatic prostate cancer (1.3) • Gastric Adenocarcinoma (GC): with cisplatin and fluorouracil for untreated, advanced GC, including the gastroesophageal junction (1.4) • Squamous Cell Carcinoma of the Head and Neck Cancer (SCCHN): with cisplatin and fluorouracil for induction treatment of locally advanced SCCHN (1.5) 1.1 Breast Cancer Docetaxel Injection is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior chemotherapy. Docetaxel Injection in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node-positive breast cancer. 1.2 Non-Small Cell Lung Cancer Docetaxel Injection as a single agent is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy. Docetaxel Injection in combination with cisplatin is indicated for the treatment of patients with unresectable, locally advanced or metastatic non-small cell lung cancer who have not previously received chemotherapy for this condition. 1.3 Prostate Cancer Docetaxel Injection in combination with prednisone is indicated for the treatment of patients with androgen independent (hormone refractory) metastatic prostate cancer. 1.4 Gastric Adenocarcinoma Docetaxel Injection in combination with cisplatin and fluorouracil is indicated for the treatment of patients with advanced gastric adenocarcinoma, including adenocarcinoma of the gastroesophageal junction, who have not received prior chemotherapy for advanced disease. 1.5 Head and Neck Cancer Docetaxel Injection in combination with cisplatin and fluorouracil is indicated for the induction treatment of patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
Is Docetaxel | Sandoz Inc. usage safe while breastfeeding? If a lactating mother is using it can there be any effect on growth or development of infant?
Our analysis of Docetaxel anhydrous which are active ingredients in Docetaxel | Sandoz Inc. indicates that Docetaxel | Sandoz Inc. is dangerous to use in breastfeeding. We strongly recommend you to go through detailed analysis of Docetaxel anhydrous as below and do not use Docetaxel | Sandoz Inc. during breastfeeding.
Statement of Manufacturer/Labeler about breastfeeding usage
8.3 Nursing Mothers It is not known whether docetaxel is excreted in human milk. Because many drugs are excreted in human milk, and because of the potential for serious adverse reactions in nursing infants from Docetaxel Injection a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.
Docetaxel | Sandoz Inc. Breastfeeding Analsys
Docetaxel anhydrous while Breastfeeding Dangerous
CAS Number: 114977-28-5
Drug is cleared from the body in 10 elimination half-lives. Resuming breastfeeding is likely safe after 5 days of pumping-and-dumping.
Docetaxel | Sandoz Inc. Breastfeeding Analsys - 2
Docetaxel anhydrous while Breastfeeding
CAS Number: 148408-66-6
Most sources consider breastfeeding to be contraindicated during maternal antineoplastic drug therapy. No information is available on the clinical use of docetaxel during breastfeeding. Chemotherapy may adversely affect the normal microbiome and chemical makeup of breastmilk. Women who receive chemotherapy during pregnancy are more likely to have difficulty nursing their infant.
What should I do if I am breastfeeding mother and I am already exposed to Docetaxel | Sandoz Inc.?
You should immediately inform your health care provider about Docetaxel | Sandoz Inc. usage and your breastfeeding interval after usage of . If you feel baby is having abnormal behavior or any other health issue please call 911 immediately or contact nearest medical emergency center.
I am nursing mother and my doctor has suggested me to use Docetaxel | Sandoz Inc., is it safe?
Please double check with your doctor if he is aware of your breastfeeding stratus, Ask your doctor if there is any safe alternative of Docetaxel | Sandoz Inc.. Check with your doctor if you shall temporally stop breastfeeding. You may go for second opinion as well. Still after all of this if your doctor still recommends Docetaxel | Sandoz Inc. then go for it as they have access on more detailed medical and scientific information and they understand your individual medical situation much better.
If I am using Docetaxel | Sandoz Inc., will my baby need extra monitoring?
Extreme level of monitoring required as Docetaxel | Sandoz Inc. could be dangerous for kid.
Who can I talk to if I have questions about usage of Docetaxel | Sandoz Inc. in breastfeeding?
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week